Jonathan H. Davis - Concepedia

Concepedia

Author

Jonathan H. Davis

Bristol-Myers Squibb (United States)ORCID

Also Known As

JONATHAN H. DAVIS, Jonathan Davis, Jonathan H Davis, Jonathan H. Davis, Jonathan H. Davis

21

Publications

1.2K

Citations

14

H-Index

32

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Howard Hughes Medical Institute University of California, San Francisco Massachusetts General Hospital Harvard University

JH

About

Jonathan H. Davis is an author at Bristol-Myers Squibb (United States) specializing in medicine, structural biology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	526
2	Natural Sciences	2	2	267
3	Biochemistry	2	2	267
4	Engineering	1	1	232
5	Cell Biology	1	1	27

Jonathan H. Davis

×

15

Publications

1.2K

Citations

14

H-Index

	Year	Citations
Informational Complexity and Functional Activity of RNA Structures James M. Carothers, Stephanie Oestreich, Jonathan H. Davis, Journal of the American Chemical Society Sequence MotifFunctional UtilityFunctional GenomicsEngineeringMolecular Diversity	2004	232
SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies† Jonathan H. Davis, Christel Aperlo, Yue Li, Protein Engineering Design and Selection	2010	185
Isolation of high-affinity GTP aptamers from partially structured RNA libraries Jonathan H. Davis, Jack W. Szostak Proceedings of the National Academy of Sciences	2002	170
Energetic landscape of α-lytic protease optimizes longevity through kinetic stability Sheila S. Jaswal, Julie L. Sohl, Jonathan H. Davis, Nature Protein ChemistryProtein FunctionBiochemistryProtein FoldingNatural Sciences	2002	162
Solution structure of .omega.-conotoxin GVIA using 2-D NMR spectroscopy and relaxation matrix analysis Jonathan H. Davis, Erin K. Bradley, George P. Miljanich, Biochemistry Omega-conotoxin GviaPeptide AntagonistRelaxation Matrix AnalysisMolecular DynamicsMedicinal Chemistry	1993	105
IL-2/CD25: A Long-Acting Fusion Protein That Promotes Immune Tolerance by Selectively Targeting the IL-2 Receptor on Regulatory T Cells Natasha C. Ward, Aixin Yu, Alejandro Moro, The Journal of Immunology	2018	90
Structures of Adnectin/Protein Complexes Reveal an Expanded Binding Footprint Vidhyashankar Ramamurthy, Stanley R. Krystek, Alexander A. Bush, Structure	2012	88
Solution structure of an informationally complex high-affinity RNA aptamer to GTP James M. Carothers, Jonathan H. Davis, James J. Chou, RNA	2006	75
Design and characterization of mouse IgG1 and IgG2a bispecific antibodies for use in syngeneic models Feng Wang, Jordan C. Tsai, Jonathan H. Davis, mAbs Immunocytochemical TechniqueTransgenic Mouse ModelsImmunologyAntibody PairIgg2a Bispecific Antibodies	2019	27
Relationship between Enzyme Specificity and the Backbone Dynamics of Free and Inhibited α-Lytic Protease<sup>,</sup> Jonathan H. Davis, David A. Agard Biochemistry	1998	21

Page 1